These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 32040344)

  • 21. The role of EMG1 in lung adenocarcinoma progression: Implications for prognosis and immune cell infiltration.
    Wu X; Wu Z; Xie Z; Huang H; Wang Y; Lv K; Yang H; Liu X
    Int Immunopharmacol; 2024 Sep; 138():112553. PubMed ID: 38943975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
    Dong M; Yang Z; Li X; Zhang Z; Yin A
    Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers.
    Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ
    J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High
    Xie L; Dang Y; Guo J; Sun X; Xie T; Zhang L; Yan Z; Amin H; Guo X
    Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RPL22L1 is a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma, promoting the growth and metastasis of LUAD cells by inhibiting the MDM2/P53 signaling pathway.
    Xing S; Li D; Zhao Q
    Aging (Albany NY); 2024 Aug; 16(17):12392-12413. PubMed ID: 39207452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma.
    Jin CY; Du L; Nuerlan AH; Wang XL; Yang YW; Guo R
    Aging (Albany NY); 2020 Dec; 13(3):3518-3535. PubMed ID: 33411689
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Yu J; Hou M; Pei T
    DNA Cell Biol; 2020 May; 39(5):890-899. PubMed ID: 32282228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
    Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
    BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
    Chen A; Ding S; Shen X; Lin X
    Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
    Wang H; Wei C; Pan P; Yuan F; Cheng J
    Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
    Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
    Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of GSDMC is a prognostic factor for predicting a poor outcome in lung adenocarcinoma.
    Wei J; Xu Z; Chen X; Wang X; Zeng S; Qian L; Yang X; Ou C; Lin W; Gong Z; Yan Y
    Mol Med Rep; 2020 Jan; 21(1):360-370. PubMed ID: 31939622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of PRDX4 and the EGFR mutation status on cellular proliferation in lung adenocarcinoma.
    Mizutani K; Guo X; Shioya A; Zhang J; Zheng J; Kurose N; Ishibashi H; Motono N; Uramoto H; Yamada S
    Int J Med Sci; 2019; 16(9):1199-1206. PubMed ID: 31588184
    [No Abstract]   [Full Text] [Related]  

  • 35. Low expression of LINC00982 and PRDM16 is associated with altered gene expression, damaged pathways and poor survival in lung adenocarcinoma.
    Lv W; Yu X; Li W; Feng N; Feng T; Wang Y; Lin H; Qian B
    Oncol Rep; 2018 Nov; 40(5):2698-2709. PubMed ID: 30132554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated expression of
    Feng Z; Zhang J; Zheng Y; Wang Q; Min X; Tian T
    Per Med; 2021 Mar; 18(2):115-127. PubMed ID: 33576264
    [No Abstract]   [Full Text] [Related]  

  • 37. High GJB2 mRNA expression and its prognostic significance in lung adenocarcinoma: a study based on the TCGA database.
    Tang Y; Zhang YJ; Wu ZH
    Medicine (Baltimore); 2020 Apr; 99(14):e19054. PubMed ID: 32243356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide investigation of the clinical significance and prospective molecular mechanism of minichromosome maintenance protein family genes in patients with Lung Adenocarcinoma.
    Liu K; Kang M; Liao X; Wang R
    PLoS One; 2019; 14(7):e0219467. PubMed ID: 31323040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogenic role of abnormal spindle‑like microcephaly‑associated protein in lung adenocarcinoma.
    Wang J; Liang J; Li H; Han J; Jiang J; Li Y; Feng Z; Zhao R; Tian H
    Int J Oncol; 2021 May; 58(5):. PubMed ID: 33786609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.
    Schlensog M; Magnus L; Heide T; Eschenbruch J; Steib F; Tator M; Kloten V; Rose M; Noetzel E; Gaisa NT; Knüchel R; Dahl E
    Epigenetics; 2018; 13(3):214-227. PubMed ID: 27623992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.